<DOC>
	<DOC>NCT01157559</DOC>
	<brief_summary>The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.</brief_summary>
	<brief_title>Efficacy and Safety With Ziprasidone in First-episode Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Patients who meet DSMIV criteria for first episode schizophrenia, schizophreniform disorder and schizoaffective disorder Patients with previously prescribed antipsychotic medication in 2 weeks or more patients with substanceinduced psychotic disorder, serious suicide attempt, neurological disorder, etc.</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>